Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

NCT Number	NCT07143669
Lead Sponsor	Blueprint Medicines Corporation
Conditions	Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease
Enrollment	750 participants
Start Date	2025-10-17
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-12